Cart
sales@molnova.com
CAY10678
CAS No. 1268709-57-4
CAY10678( —— )
Catalog No. M35031 CAS No. 1268709-57-4
CAY10678 is an mPGES-1 inhibitor that inhibits PD-1.CAY10678 reduces collagen deposition and T-cell depletion, and may be used to study melanoma.CASHIPS
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 117 | In Stock |
|
| 10MG | 180 | In Stock |
|
| 25MG | 353 | In Stock |
|
| 50MG | 523 | In Stock |
|
| 100MG | 737 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1516 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCAY10678
-
NoteResearch use only, not for human use.
-
Brief DescriptionCAY10678 is an mPGES-1 inhibitor that inhibits PD-1.CAY10678 reduces collagen deposition and T-cell depletion, and may be used to study melanoma.CASHIPS
-
DescriptionCAY10678 is an mPGES-1 inhibitor that inhibits PD-1.CAY10678 reduces collagen deposition and T-cell depletion, and may be used to study melanoma.CASHIPS
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetPD-1/PD-L1
-
RecptorPD-1/PD-L1 | Prostaglandin Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1268709-57-4
-
Formula Weight382.54
-
Molecular FormulaC23H34N4O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC1CCCC1)C2CCN(C3=NC=4C=C(C(=CC4N3C(C)C)C)C)CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Spartalizumab
Spartalizumab (PDR001) is a humanized immunoglobulin G4 monoclonal antibody that selectively binds to PD-1 at low concentrations, exhibiting high activity.
-
BMS-1166-N-piperidin...
BMS-1166-N-piperidine-CO-N-piperazine dihydrochloride, a resorcinol di-Ph ether scaffold-based programmed cell death-1 (PD-1)/programmed cell death ligand 1 (PD-L1) inhibitor, inhibits the PD-1/PD-L1 interaction with an IC50 of 39.2 nM.
-
Nofazinlimab
Nofazinlimab (CS1003) is a human anti-PD-1 IgG4 monoclonal antibody used to study unresectable hepatocellular carcinoma (uHCC) and metastatic colorectal cancer.
